Bio-Techne Corporation
TECH
$48.21
$0.841.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.22B | 1.22B | 1.22B | 1.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.21B | 1.22B | 1.22B | 1.22B | 1.21B |
| Cost of Revenue | 406.84M | 405.94M | 403.53M | 408.52M | 403.75M |
| Gross Profit | 803.97M | 809.63M | 813.20M | 811.12M | 805.02M |
| SG&A Expenses | 403.62M | 447.07M | 456.38M | 452.60M | 494.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 910.74M | 954.42M | 963.20M | 964.04M | 990.36M |
| Operating Income | 300.07M | 261.16M | 253.53M | 255.59M | 218.41M |
| Income Before Tax | 147.14M | 114.19M | 106.28M | 98.46M | 162.98M |
| Income Tax Expenses | 37.58M | 33.09M | 28.30M | 25.06M | 31.32M |
| Earnings from Continuing Operations | 109.56 | 81.10 | 77.99 | 73.40 | 131.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.56M | 81.10M | 77.99M | 73.40M | 131.67M |
| EBIT | 300.07M | 261.16M | 253.53M | 255.59M | 218.41M |
| EBITDA | 400.40M | 364.89M | 359.64M | 365.50M | 329.26M |
| EPS Basic | 0.70 | 0.52 | 0.50 | 0.46 | 0.83 |
| Normalized Basic EPS | 1.18 | 1.04 | 1.00 | 1.01 | 0.83 |
| EPS Diluted | 0.68 | 0.50 | 0.48 | 0.45 | 0.83 |
| Normalized Diluted EPS | 1.17 | 1.03 | 1.00 | 1.00 | 0.82 |
| Average Basic Shares Outstanding | 622.54M | 623.59M | 626.18M | 629.25M | 632.20M |
| Average Diluted Shares Outstanding | 626.52M | 628.06M | 631.69M | 636.44M | 641.34M |
| Dividend Per Share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 45.47% | 61.50% | 64.30% | 68.65% | 38.45% |